Lifecore Biomedical, Inc. (LFCR): Valuation
TTM figures as of May 25, 2025
Lifecore Biomedical, Inc. trades at a -8.73% free-cash-flow yield. That FCF yield is higher than 27% of its own month-end history back to 2011.
Earnings yield -24.83%. ROIC -10.5%. Piotroski F-score 3 of 9. Net debt $128.1M.
184 month-end valuation observations are on file, starting May 2011.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is LFCR cheap versus its own history?
Lifecore Biomedical, Inc. trades at a -8.73% free-cash-flow yield. That FCF yield is higher than 27% of its own month-end history back to 2011.
What is LFCR's free-cash-flow yield?
Lifecore Biomedical, Inc. currently yields -8.73% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.